T cells tagged posts

Nanodiscs deliver Personalized Cancer therapy to Immune system

Design of sHDL nanodisc platform for personalized cancer vaccines.

Design of sHDL nanodisc platform for personalized cancer vaccines.

Researchers at the University of Michigan have had initial success in mice using nanodiscs to deliver a customized therapeutic vaccine for the treatment of colon and melanoma cancer tumors. “We are basically educating the immune system with these nanodiscs so that immune cells can attack cancer cells in a personalized manner,” said James Moon, the John Gideon Searle assistant professor of pharmaceutical sciences and biomedical engineering.

Personalized immunotherapy is a fast-growing field of research in the fight against cancer. The therapeutic cancer vaccine employs nanodiscs loaded with tumor neoantigens, unique mutations found in tumor cells...

Read More

Microneedle Patch delivers localized Cancer Immunotherapy to Melanoma

Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody.

Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody.

Biomedical engineering researchers have developed a technique that uses a patch embedded with microneedles to deliver cancer immunotherapy treatment directly to the site of melanoma skin cancer. In animal studies, the technique more effectively targeted melanoma than other immunotherapy treatments.

More than 67,000 people in the US were diagnosed with melanoma in 2012 alone – the most recent year for which data are available. If caught early, melanoma patients have a 5yr survival rate of more than 98%. That number dips to 16.6% if the cancer has metastasized before diagnosis and treatment.

Cancer cells can trick T cells...

Read More

Rapid Aging of the Thymus linked to Decline in Free Radical Defenses

 

A new study reveals that thymus atrophy may stem from a decline in its ability to protect against DNA damage from free radicals. The damage accelerates metabolic dysfunction in the organ, progressively reducing its production of pathogen-fighting T cells. Common antioxidants may slow thymus atrophy and be a Rx strategy for protecting elderly from infections.

“The thymus ages more rapidly than any other tissue in the body, diminishing the ability of older individuals to respond to new immunologic challenges, including evolving pathogens and the vaccines that may otherwise offer protection from them,” says Howard Petrie of SRI. Starting around puberty, the thymus rapidly decreases in size and loses capacity to produce enough new T cells...

Read More

Research Reveals New Details about how the Immune System refines its Antibodies

   

The immune system produces antibodies finely tuned to antigens. Recent research describes how the interaction between T cells (green) and B cells (blue) allows this to take place. Bystander B cells and antigen appear in red. Credit: Laboratory of Molecular Immunology at The Rockefeller University

The immune system produces antibodies finely tuned to antigens. Recent research describes how the interaction between T cells (green) and B cells (blue) allows this to take place. Bystander B cells and antigen appear in red.
Credit: Laboratory of Molecular Immunology at The Rockefeller University

Cell Division speeds up as part of antibody selection. Mechanisms that favor selection of B cells capable of producing antibodies with highest affinity for that invader. “2 of the mechanisms that allow high affinity B cells to overwhelm the others,” says Alex Gitlin.

During an infection, B + other immune cells form germinal centers in spleen and lymph nodes, where B cells evolve in a Darwinian-like fashion...

Read More